Analyst Activity – Canaccord Genuity Sets Its Price Target On Celgene Corporation (NASDAQ:CELG) of

ME Staff
-
0

Analyst Ratings For Celgene Corporation (NASDAQ:CELG)

Today, Canaccord Genuity set its price target on Celgene Corporation (NASDAQ:CELG) of per share.

There are 1 sell rating, 5 hold ratings, 20 buy ratings on the stock.

The current consensus rating on Celgene Corporation (NASDAQ:CELG) is Buy (Score: 2.73) with a consensus target price of $141.96 per share, a potential 5.86% upside.

Some recent analyst ratings include

  • 7/28/2017-Stifel Nicolaus initiated coverage with a Buy rating.
  • 7/27/2017-Cowen and Company Reiterated Rating of Outperform.
  • 7/21/2017-Robert W. Baird Reiterated Rating of Outperform.
  • 7/14/2017-SunTrust Banks, Inc. Reiterated Rating of Buy.

Recent Insider Trading Activity For Celgene Corporation (NASDAQ:CELG)
Celgene Corporation (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 78.39%.

  • On 6/26/2017 James J Loughlin, Director, sold 18,500 with an average share price of $133.57 per share and the total transaction amounting to $2,471,045.00. View SEC Filing
  • On 6/22/2017 Michael A Friedman, Director, sold 10,000 with an average share price of $132.50 per share and the total transaction amounting to $1,325,000.00. View SEC Filing
  • On 6/22/2017 Robert J Hugin, Insider, sold 175,970 with an average share price of $134.14 per share and the total transaction amounting to $23,604,615.80. View SEC Filing
  • On 6/21/2017 Michael D Casey, Director, sold 9,250 with an average share price of $133.05 per share and the total transaction amounting to $1,230,712.50. View SEC Filing
  • On 6/19/2017 Michael D. Casey, Director, sold 9,250 with an average share price of $125.59 per share and the total transaction amounting to $1,161,707.50. View SEC Filing
  • On 6/15/2017 Rupert Vessey, Insider, sold 4,785 with an average share price of $120.18 per share and the total transaction amounting to $575,061.30. View SEC Filing
  • On 5/1/2017 James J Loughlin, Director, sold 9,250 with an average share price of $124.00 per share and the total transaction amounting to $1,147,000.00. View SEC Filing

Recent Trading Activity for Celgene Corporation (NASDAQ:CELG)
Shares of Celgene Corporation closed the previous trading session at 134.10 down -0.05 -0.04% with 3,771,910 shares trading hands.